MEDVi vs Wisp
Wisp costs $150 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between MEDVi and Wisp, the first difference is cost: Wisp is $150 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. MEDVi leads our six-part score, 7.1 to 6.5. One of the two has an FDA warning letter on record, covered below.
MEDVi vs Wisp price
Wisp is the cheaper way in: $99 a month against $249 a month at MEDVi. That is $150 less each month (60% lower), or about $1,800 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Wisp ($225 a month vs $249 a month).
Medications and formats
Both sell semaglutide; only Wisp lists tirzepatide.
On format, MEDVi prices compounded injections, while Wisp prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Wisp is the only one of the two with a brand-name price.
Where each one treats patients
MEDVi lists 48 states, and Wisp does not publish where it ships.
Pricing
MEDVi
Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.
Flat 'Starting at $249' — no intro discount shown.
$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'
$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.
Wisp
Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.
Zepbound $99/mo (compounded sublingual semaglutide $225/mo)
What each price covers
Both prices cover the medication itself and shipping.
MEDVi's price also covers the clinician visit and coaching, which Wisp does not claim.
MEDVi is silent on lab work.
Wisp is silent on the clinician visit, lab work and coaching.
MEDVi
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Wisp
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, MEDVi scores 7.1 and Wisp 6.5 out of 10.
MEDVi is stronger on accessibility (9.7 vs 5.0) and support (8.5 vs 4.5).
Wisp is stronger on value (3.5 vs 2.8) and trust & safety (6.5 vs 6.0).
Effectiveness and user experience are within half a point.
MEDVi
7.1/10
Wisp
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.
Wisp has no FDA warning letter on record with us.
Features & Coverage
| Feature | MEDVi | Wisp |
|---|---|---|
| Starting Price | $249/mo | ✓$99/mo |
| Features | 7 features | ✓8 features |
| States Available | 48 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About MEDVi
Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.
Read our full MEDVi review →About Wisp
$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.
Read our full Wisp review →Pros & Cons
MEDVi
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves 48 states
- Names 3 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Wisp
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to Wisp
Watch-outs
- Semaglutide costs $225 a month, 22% above the $184 median for compounded semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
MEDVi wins this one, 7.1 to 6.5, above all for knowing which pharmacy fills the vial: it names Triad Rx. Wisp undercuts it by $150 a month, so if the monthly bill is what decides it, Wisp is the pick. Wisp fits better if an oral route if you will not self-inject is your priority.
Choose MEDVi if…
You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.
Choose Wisp if…
You want an oral route if you will not self-inject and an opening price near $99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →MEDVi vs Wisp: FAQ
Close alternatives to MEDVi and Wisp
- MEDVi vs Cabana
- MEDVi vs Next Vial
- MEDVi vs Tell Her Doc
- MEDVi vs LIV by WellNow
- Wisp vs GobyMeds
- Wisp vs HeliMeds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.